366 related articles for article (PubMed ID: 23653307)
1. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism.
Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS
Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307
[TBL] [Abstract][Full Text] [Related]
2. Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment.
Foresta C; Di Mambro A; Caretta N; De Toni L; Zuccarello D; Ferlin A
Clin Endocrinol (Oxf); 2009 Sep; 71(3):412-6. PubMed ID: 19094070
[TBL] [Abstract][Full Text] [Related]
3. Reduced number of circulating endothelial progenitor cells in hypogonadal men.
Foresta C; Caretta N; Lana A; De Toni L; Biagioli A; Ferlin A; Garolla A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4599-602. PubMed ID: 16926245
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
6. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
Reyes-Vallejo L; Lazarou S; Morgentaler A
J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
[TBL] [Abstract][Full Text] [Related]
7. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
8. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL; Morgentaler A
Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
[TBL] [Abstract][Full Text] [Related]
9. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
[TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy for late-onset hypogonadism.
Cunningham GR
Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
[TBL] [Abstract][Full Text] [Related]
13. Reduced endothelial progenitor cell number and function in inflammatory bowel disease: a possible link to the pathogenesis.
Garolla A; D'Incà R; Checchin D; Biagioli A; De Toni L; Nicoletti V; Scarpa M; Bolzonello E; Sturniolo GC; Foresta C
Am J Gastroenterol; 2009 Oct; 104(10):2500-7. PubMed ID: 19568231
[TBL] [Abstract][Full Text] [Related]
14. Endothelial progenitor cells are reduced in refractory hypertension.
Oliveras A; Soler MJ; Martínez-Estrada OM; Vázquez S; Marco-Feliu D; Vila JS; Vilaró S; Lloveras J
J Hum Hypertens; 2008 Mar; 22(3):183-90. PubMed ID: 17992252
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
16. Low-dose growth hormone administration mobilizes endothelial progenitor cells in healthy adults.
Devin JK; Vaughan DE; Blevins LS; Chen Q; Covington J; Verity DK; Young PP
Growth Horm IGF Res; 2008 Jun; 18(3):253-63. PubMed ID: 18166495
[TBL] [Abstract][Full Text] [Related]
17. Testim 1% testosterone gel for the treatment of male hypogonadism.
Bouloux P
Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
[TBL] [Abstract][Full Text] [Related]
18. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
Mulhall JP; Valenzuela R; Aviv N; Parker M
Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training.
Thijssen DH; Vos JB; Verseyden C; van Zonneveld AJ; Smits P; Sweep FC; Hopman MT; de Boer HC
Aging Cell; 2006 Dec; 5(6):495-503. PubMed ID: 17081158
[TBL] [Abstract][Full Text] [Related]
20. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
